nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.07	0.15	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.0685	0.147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0402	0.0861	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0394	0.0843	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0368	0.0788	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.036	0.0771	CbGpPWpGaD
Carboprost Tromethamine—Dinoprost Tromethamine—HPGDS—liver cancer	0.0329	0.565	CrCbGaD
Carboprost Tromethamine—Dinoprostone—HPGDS—liver cancer	0.0253	0.435	CrCbGaD
Carboprost Tromethamine—Respiratory distress—Sorafenib—liver cancer	0.0213	0.0449	CcSEcCtD
Carboprost Tromethamine—Septic shock—Epirubicin—liver cancer	0.0166	0.0349	CcSEcCtD
Carboprost Tromethamine—Septic shock—Doxorubicin—liver cancer	0.0153	0.0323	CcSEcCtD
Carboprost Tromethamine—Venous thrombosis—Epirubicin—liver cancer	0.00927	0.0195	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Sorafenib—liver cancer	0.00898	0.0189	CcSEcCtD
Carboprost Tromethamine—Venous thrombosis—Doxorubicin—liver cancer	0.00858	0.0181	CcSEcCtD
Carboprost Tromethamine—Hyperventilation—Epirubicin—liver cancer	0.00727	0.0153	CcSEcCtD
Carboprost Tromethamine—Haematemesis—Epirubicin—liver cancer	0.0072	0.0152	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Sorafenib—liver cancer	0.00715	0.015	CcSEcCtD
Carboprost Tromethamine—Hyperventilation—Doxorubicin—liver cancer	0.00673	0.0142	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—TRIO—liver cancer	0.00672	0.0144	CbGpPWpGaD
Carboprost Tromethamine—Haematemesis—Doxorubicin—liver cancer	0.00667	0.014	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—TRIO—liver cancer	0.00658	0.0141	CbGpPWpGaD
Carboprost Tromethamine—Tinnitus—Sorafenib—liver cancer	0.00634	0.0133	CcSEcCtD
Carboprost Tromethamine—Flushing—Sorafenib—liver cancer	0.00631	0.0133	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Epirubicin—liver cancer	0.00613	0.0129	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRIO—liver cancer	0.00601	0.0129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRIO—liver cancer	0.00589	0.0126	CbGpPWpGaD
Carboprost Tromethamine—Extravasation—Epirubicin—liver cancer	0.00574	0.0121	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Sorafenib—liver cancer	0.00569	0.012	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Doxorubicin—liver cancer	0.00567	0.0119	CcSEcCtD
Carboprost Tromethamine—Angioedema—Sorafenib—liver cancer	0.00541	0.0114	CcSEcCtD
Carboprost Tromethamine—Syncope—Sorafenib—liver cancer	0.00531	0.0112	CcSEcCtD
Carboprost Tromethamine—Extravasation—Doxorubicin—liver cancer	0.00531	0.0112	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Sorafenib—liver cancer	0.0052	0.011	CcSEcCtD
Carboprost Tromethamine—Cough—Sorafenib—liver cancer	0.00517	0.0109	CcSEcCtD
Carboprost Tromethamine—Hypertension—Sorafenib—liver cancer	0.00511	0.0108	CcSEcCtD
Carboprost Tromethamine—Myalgia—Sorafenib—liver cancer	0.00504	0.0106	CcSEcCtD
Carboprost Tromethamine—Hiccups—Epirubicin—liver cancer	0.00501	0.0105	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00498	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00488	0.0105	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Sorafenib—liver cancer	0.00483	0.0102	CcSEcCtD
Carboprost Tromethamine—Infection—Sorafenib—liver cancer	0.0048	0.0101	CcSEcCtD
Carboprost Tromethamine—Shock—Sorafenib—liver cancer	0.00475	0.01	CcSEcCtD
Carboprost Tromethamine—Hiccups—Doxorubicin—liver cancer	0.00463	0.00975	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Epirubicin—liver cancer	0.0046	0.00968	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Epirubicin—liver cancer	0.00446	0.00938	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0044	0.00927	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Sorafenib—liver cancer	0.00431	0.00907	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00427	0.00915	CbGpPWpGaD
Carboprost Tromethamine—Cramps of lower extremities—Doxorubicin—liver cancer	0.00425	0.00896	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Epirubicin—liver cancer	0.00422	0.00888	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00418	0.00895	CbGpPWpGaD
Carboprost Tromethamine—Pain—Sorafenib—liver cancer	0.00413	0.0087	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Doxorubicin—liver cancer	0.00412	0.00868	CcSEcCtD
Carboprost Tromethamine—Eye pain—Epirubicin—liver cancer	0.00402	0.00847	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Doxorubicin—liver cancer	0.0039	0.00821	CcSEcCtD
Carboprost Tromethamine—Hot flush—Epirubicin—liver cancer	0.00388	0.00818	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Epirubicin—liver cancer	0.00385	0.0081	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Sorafenib—liver cancer	0.00382	0.00804	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00375	0.0079	CcSEcCtD
Carboprost Tromethamine—Eye pain—Doxorubicin—liver cancer	0.00372	0.00784	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PRKCE—liver cancer	0.00371	0.00795	CbGpPWpGaD
Carboprost Tromethamine—Lethargy—Epirubicin—liver cancer	0.00371	0.0078	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PRKCE—liver cancer	0.00363	0.00778	CbGpPWpGaD
Carboprost Tromethamine—Hot flush—Doxorubicin—liver cancer	0.00359	0.00756	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Doxorubicin—liver cancer	0.00356	0.0075	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Sorafenib—liver cancer	0.00356	0.00749	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00347	0.00731	CcSEcCtD
Carboprost Tromethamine—Asthenia—Sorafenib—liver cancer	0.00347	0.0073	CcSEcCtD
Carboprost Tromethamine—Lethargy—Doxorubicin—liver cancer	0.00343	0.00722	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00332	0.00711	CbGpPWpGaD
Carboprost Tromethamine—Abdominal pain upper—Epirubicin—liver cancer	0.00332	0.00698	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Sorafenib—liver cancer	0.00331	0.00696	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR4—liver cancer	0.00325	0.00697	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00325	0.00696	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Sorafenib—liver cancer	0.0032	0.00673	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR4—liver cancer	0.00318	0.00682	CbGpPWpGaD
Carboprost Tromethamine—Asthma—Epirubicin—liver cancer	0.00314	0.00661	CcSEcCtD
Carboprost Tromethamine—Vomiting—Sorafenib—liver cancer	0.00307	0.00647	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Doxorubicin—liver cancer	0.00307	0.00646	CcSEcCtD
Carboprost Tromethamine—Rash—Sorafenib—liver cancer	0.00305	0.00641	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Sorafenib—liver cancer	0.00304	0.00641	CcSEcCtD
Carboprost Tromethamine—Headache—Sorafenib—liver cancer	0.00303	0.00637	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00292	0.00614	CcSEcCtD
Carboprost Tromethamine—Asthma—Doxorubicin—liver cancer	0.00291	0.00612	CcSEcCtD
Carboprost Tromethamine—Nausea—Sorafenib—liver cancer	0.00287	0.00604	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Epirubicin—liver cancer	0.0028	0.00589	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Epirubicin—liver cancer	0.00272	0.00573	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.0027	0.00568	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Epirubicin—liver cancer	0.00264	0.00556	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Doxorubicin—liver cancer	0.00259	0.00545	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—F2—liver cancer	0.00258	0.00552	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—F2—liver cancer	0.00252	0.0054	CbGpPWpGaD
Carboprost Tromethamine—Urinary tract infection—Doxorubicin—liver cancer	0.00252	0.0053	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CHN2—liver cancer	0.00248	0.0053	CbGpPWpGaD
Carboprost Tromethamine—Epistaxis—Doxorubicin—liver cancer	0.00244	0.00514	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CHN2—liver cancer	0.00242	0.00519	CbGpPWpGaD
Carboprost Tromethamine—Tinnitus—Epirubicin—liver cancer	0.00234	0.00493	CcSEcCtD
Carboprost Tromethamine—Flushing—Epirubicin—liver cancer	0.00233	0.00491	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.0023	0.00494	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IFT88—liver cancer	0.00226	0.00485	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00226	0.00483	CbGpPWpGaD
Carboprost Tromethamine—Chills—Epirubicin—liver cancer	0.00226	0.00475	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IFT88—liver cancer	0.00222	0.00475	CbGpPWpGaD
Carboprost Tromethamine—Tinnitus—Doxorubicin—liver cancer	0.00217	0.00456	CcSEcCtD
Carboprost Tromethamine—Flushing—Doxorubicin—liver cancer	0.00216	0.00454	CcSEcCtD
Carboprost Tromethamine—Tension—Epirubicin—liver cancer	0.00215	0.00452	CcSEcCtD
Carboprost Tromethamine—Nervousness—Epirubicin—liver cancer	0.00213	0.00447	CcSEcCtD
Carboprost Tromethamine—Back pain—Epirubicin—liver cancer	0.00212	0.00445	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Epirubicin—liver cancer	0.0021	0.00443	CcSEcCtD
Carboprost Tromethamine—Chills—Doxorubicin—liver cancer	0.00209	0.00439	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Epirubicin—liver cancer	0.00206	0.00434	CcSEcCtD
Carboprost Tromethamine—Tension—Doxorubicin—liver cancer	0.00199	0.00418	CcSEcCtD
Carboprost Tromethamine—Nervousness—Doxorubicin—liver cancer	0.00197	0.00414	CcSEcCtD
Carboprost Tromethamine—Vertigo—Epirubicin—liver cancer	0.00197	0.00414	CcSEcCtD
Carboprost Tromethamine—Syncope—Epirubicin—liver cancer	0.00196	0.00413	CcSEcCtD
Carboprost Tromethamine—Back pain—Doxorubicin—liver cancer	0.00196	0.00412	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Doxorubicin—liver cancer	0.00195	0.0041	CcSEcCtD
Carboprost Tromethamine—Palpitations—Epirubicin—liver cancer	0.00193	0.00407	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Epirubicin—liver cancer	0.00192	0.00405	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—TRIO—liver cancer	0.00192	0.00411	CbGpPWpGaD
Carboprost Tromethamine—Cough—Epirubicin—liver cancer	0.00191	0.00402	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Doxorubicin—liver cancer	0.00191	0.00402	CcSEcCtD
Carboprost Tromethamine—Hypertension—Epirubicin—liver cancer	0.00189	0.00398	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—TRIO—liver cancer	0.00188	0.00402	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Epirubicin—liver cancer	0.00186	0.00392	CcSEcCtD
Carboprost Tromethamine—Myalgia—Epirubicin—liver cancer	0.00186	0.00392	CcSEcCtD
Carboprost Tromethamine—Anxiety—Epirubicin—liver cancer	0.00186	0.00391	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR4—liver cancer	0.00184	0.00394	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Doxorubicin—liver cancer	0.00182	0.00383	CcSEcCtD
Carboprost Tromethamine—Syncope—Doxorubicin—liver cancer	0.00182	0.00382	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR4—liver cancer	0.0018	0.00385	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Doxorubicin—liver cancer	0.00179	0.00377	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Epirubicin—liver cancer	0.00179	0.00376	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Doxorubicin—liver cancer	0.00178	0.00375	CcSEcCtD
Carboprost Tromethamine—Infection—Epirubicin—liver cancer	0.00177	0.00373	CcSEcCtD
Carboprost Tromethamine—Cough—Doxorubicin—liver cancer	0.00177	0.00372	CcSEcCtD
Carboprost Tromethamine—Shock—Epirubicin—liver cancer	0.00176	0.0037	CcSEcCtD
Carboprost Tromethamine—Hypertension—Doxorubicin—liver cancer	0.00175	0.00368	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Epirubicin—liver cancer	0.00174	0.00367	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TRIO—liver cancer	0.00174	0.00373	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00173	0.00371	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Epirubicin—liver cancer	0.00173	0.00363	CcSEcCtD
Carboprost Tromethamine—Chest pain—Doxorubicin—liver cancer	0.00172	0.00363	CcSEcCtD
Carboprost Tromethamine—Myalgia—Doxorubicin—liver cancer	0.00172	0.00363	CcSEcCtD
Carboprost Tromethamine—Anxiety—Doxorubicin—liver cancer	0.00172	0.00362	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00171	0.00366	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TRIO—liver cancer	0.0017	0.00365	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00169	0.00363	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00167	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR4—liver cancer	0.00167	0.00357	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Doxorubicin—liver cancer	0.00165	0.00348	CcSEcCtD
Carboprost Tromethamine—Infection—Doxorubicin—liver cancer	0.00164	0.00346	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR4—liver cancer	0.00163	0.0035	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00163	0.00342	CcSEcCtD
Carboprost Tromethamine—Shock—Doxorubicin—liver cancer	0.00163	0.00342	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Doxorubicin—liver cancer	0.00161	0.00339	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Epirubicin—liver cancer	0.0016	0.00338	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Doxorubicin—liver cancer	0.0016	0.00336	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Epirubicin—liver cancer	0.00159	0.00335	CcSEcCtD
Carboprost Tromethamine—Somnolence—Epirubicin—liver cancer	0.00159	0.00334	CcSEcCtD
Carboprost Tromethamine—Pain—Epirubicin—liver cancer	0.00153	0.00321	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00151	0.00317	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Doxorubicin—liver cancer	0.00148	0.00312	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Doxorubicin—liver cancer	0.00147	0.0031	CcSEcCtD
Carboprost Tromethamine—Somnolence—Doxorubicin—liver cancer	0.00147	0.00309	CcSEcCtD
Carboprost Tromethamine—Pain—Doxorubicin—liver cancer	0.00141	0.00297	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Epirubicin—liver cancer	0.00141	0.00297	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SHC3—liver cancer	0.00139	0.00297	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SHC3—liver cancer	0.00136	0.00291	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Epirubicin—liver cancer	0.00132	0.00277	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Doxorubicin—liver cancer	0.00131	0.00275	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—F2—liver cancer	0.0013	0.00278	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Epirubicin—liver cancer	0.00128	0.0027	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—F2—liver cancer	0.00127	0.00273	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Epirubicin—liver cancer	0.00122	0.00257	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Doxorubicin—liver cancer	0.00122	0.00256	CcSEcCtD
Carboprost Tromethamine—Asthenia—Doxorubicin—liver cancer	0.00119	0.0025	CcSEcCtD
Carboprost Tromethamine—Dizziness—Epirubicin—liver cancer	0.00118	0.00249	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—liver cancer	0.00115	0.00247	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Epirubicin—liver cancer	0.00114	0.00239	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Doxorubicin—liver cancer	0.00113	0.00238	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—liver cancer	0.00113	0.00242	CbGpPWpGaD
Carboprost Tromethamine—Rash—Epirubicin—liver cancer	0.00113	0.00237	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Epirubicin—liver cancer	0.00113	0.00237	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00112	0.0024	CbGpPWpGaD
Carboprost Tromethamine—Headache—Epirubicin—liver cancer	0.00112	0.00235	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.0011	0.00235	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Doxorubicin—liver cancer	0.00109	0.0023	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FST—liver cancer	0.00108	0.00231	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Epirubicin—liver cancer	0.00106	0.00223	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PRKCE—liver cancer	0.00106	0.00227	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FST—liver cancer	0.00105	0.00226	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Doxorubicin—liver cancer	0.00105	0.00221	CcSEcCtD
Carboprost Tromethamine—Rash—Doxorubicin—liver cancer	0.00104	0.00219	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Doxorubicin—liver cancer	0.00104	0.00219	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PRKCE—liver cancer	0.00104	0.00222	CbGpPWpGaD
Carboprost Tromethamine—Headache—Doxorubicin—liver cancer	0.00104	0.00218	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00103	0.00221	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TRIO—liver cancer	0.00103	0.0022	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00101	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TRIO—liver cancer	0.00101	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR4—liver cancer	0.000986	0.00211	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Doxorubicin—liver cancer	0.000982	0.00207	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR4—liver cancer	0.000965	0.00207	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PRKCE—liver cancer	0.000961	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000953	0.00204	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PRKCE—liver cancer	0.00094	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CSF2—liver cancer	0.000936	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000933	0.002	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CSF2—liver cancer	0.000916	0.00196	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000912	0.00195	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000893	0.00191	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CSF2—liver cancer	0.00085	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CSF2—liver cancer	0.000832	0.00178	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADAM17—liver cancer	0.000779	0.00167	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADAM17—liver cancer	0.000763	0.00163	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—F2—liver cancer	0.000734	0.00157	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSMD10—liver cancer	0.000732	0.00157	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSMA4—liver cancer	0.000732	0.00157	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—F2—liver cancer	0.000719	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSMD10—liver cancer	0.000717	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSMA4—liver cancer	0.000717	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CG—liver cancer	0.000703	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CG—liver cancer	0.000688	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—F2—liver cancer	0.000667	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—F2—liver cancer	0.000653	0.0014	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CG—liver cancer	0.000638	0.00137	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CG—liver cancer	0.000625	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CD—liver cancer	0.000618	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CD—liver cancer	0.000605	0.0013	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PRKCE—liver cancer	0.000567	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CD—liver cancer	0.000561	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PRKCE—liver cancer	0.000555	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CD—liver cancer	0.000549	0.00118	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CB—liver cancer	0.000539	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—liver cancer	0.000538	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CB—liver cancer	0.000527	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—liver cancer	0.000526	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CSF2—liver cancer	0.000502	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAF1—liver cancer	0.000501	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—H2AFX—liver cancer	0.000495	0.00106	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—liver cancer	0.000495	0.00106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CSF2—liver cancer	0.000491	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAF1—liver cancer	0.00049	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CB—liver cancer	0.000489	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—H2AFX—liver cancer	0.000484	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—liver cancer	0.000484	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CB—liver cancer	0.000479	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—liver cancer	0.000449	0.000962	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TERT—liver cancer	0.000447	0.000959	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—liver cancer	0.00044	0.000942	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TERT—liver cancer	0.000438	0.000938	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—liver cancer	0.000409	0.000877	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK14—liver cancer	0.000407	0.000871	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—liver cancer	0.000401	0.000858	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ESR1—liver cancer	0.000399	0.000855	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK14—liver cancer	0.000398	0.000853	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—F2—liver cancer	0.000394	0.000844	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ESR1—liver cancer	0.00039	0.000836	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—F2—liver cancer	0.000386	0.000826	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APC—liver cancer	0.000377	0.000808	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—liver cancer	0.000377	0.000808	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APC—liver cancer	0.000369	0.000791	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—liver cancer	0.000369	0.000791	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BRAF—liver cancer	0.000354	0.000759	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BRAF—liver cancer	0.000347	0.000743	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—liver cancer	0.000331	0.00071	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—liver cancer	0.000328	0.000703	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—liver cancer	0.000328	0.000702	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—liver cancer	0.000324	0.000695	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—liver cancer	0.000324	0.000695	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—liver cancer	0.000321	0.000688	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—liver cancer	0.000321	0.000687	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—liver cancer	0.000318	0.000681	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—liver cancer	0.000298	0.000639	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAF1—liver cancer	0.000296	0.000634	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—liver cancer	0.000292	0.000625	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAF1—liver cancer	0.00029	0.000621	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MTOR—liver cancer	0.000289	0.000619	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—liver cancer	0.000289	0.000619	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—liver cancer	0.000283	0.000606	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MTOR—liver cancer	0.000283	0.000606	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—liver cancer	0.000276	0.000591	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN1B—liver cancer	0.000271	0.000581	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—liver cancer	0.00027	0.000578	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—liver cancer	0.000268	0.000575	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—liver cancer	0.000266	0.000569	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN1B—liver cancer	0.000265	0.000569	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—liver cancer	0.000265	0.000568	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—liver cancer	0.000264	0.000566	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—liver cancer	0.000262	0.000562	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—liver cancer	0.00026	0.000557	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—liver cancer	0.00026	0.000556	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCND1—liver cancer	0.000259	0.000554	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—liver cancer	0.000258	0.000554	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JUN—liver cancer	0.000258	0.000553	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—liver cancer	0.000256	0.000549	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCND1—liver cancer	0.000253	0.000542	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JUN—liver cancer	0.000253	0.000541	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—liver cancer	0.000251	0.000538	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—liver cancer	0.000251	0.000537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—liver cancer	0.00025	0.000536	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—liver cancer	0.000246	0.000527	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—liver cancer	0.000245	0.000525	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK8—liver cancer	0.000244	0.000523	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—liver cancer	0.000244	0.000522	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK8—liver cancer	0.000239	0.000512	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—liver cancer	0.000238	0.000511	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—liver cancer	0.000225	0.000483	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—liver cancer	0.000223	0.000478	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—liver cancer	0.000221	0.000473	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—liver cancer	0.000219	0.000468	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—liver cancer	0.000207	0.000444	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—liver cancer	0.000207	0.000443	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—liver cancer	0.000203	0.000435	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—liver cancer	0.000203	0.000434	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KRAS—liver cancer	0.000192	0.000411	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KRAS—liver cancer	0.000188	0.000402	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—liver cancer	0.000176	0.000377	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—liver cancer	0.000172	0.000369	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—liver cancer	0.00017	0.000365	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—liver cancer	0.000167	0.000357	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRAS—liver cancer	0.000163	0.000349	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRAS—liver cancer	0.000159	0.000342	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—liver cancer	0.000156	0.000334	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—liver cancer	0.000153	0.000327	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—liver cancer	0.000144	0.000308	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—liver cancer	0.000141	0.000302	CbGpPWpGaD
